References
- Weber M, Steinle H, Golombek S, Hann L, Schlensak C, Wendel HP, Avci-Adali M. Blood-contacting biomaterials: in vitro evaluation of the hemocompatibility. Front Bioeng Biotechnol 2018;6:99.
- International Standard ISO. 10993-4: biological evaluation of medical devices - Part 4: selection of tests for interactions with blood. International Organization for Standardization ISO Central Secretariat Chemin de Blandonnet 8 CP 401 - 1214 Vernier, Geneva, Switzerland. 2017. p. 1–23.
- Simak J, De Paoli S. The effects of nanomaterials on blood coagulation in hemostasis and thrombosis. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2017;9:e1448. doi:https://doi.org/10.1002/wnan.1448
- Ilinskaya AN, Dobrovolskaia MA. Nanoparticles and the blood coagulation system. Part II: Safety Concerns Nanomedicine 2013;8(6):969–981.
- Ragaseema VM, Unnikrishnan S, Kalliyana Krishnan V, Krishnan LK. The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces. Biomater Elsevier Ltd 2012;33:3083–3092. doi:https://doi.org/10.1016/j.biomaterials.2012.01.005
- MDR 745. Regulation (EU) 2017/745 of the European parliament and of the council of 5 April 2017 on medical devices, amending directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing council directives 90/385/EEC and 93/42/EE. Off J Eur Union 2017;60:2–175.
- Dakal TC, Kumar A, Majumdar RS, Yadav V. Mechanistic basis of antimicrobial actions of silver nanoparticles. Front Microbiol 2016;7:1831. doi:https://doi.org/10.3389/fmicb.2016.01831
- Chernousova S, Epple M. Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chemie - Int Ed 2013;52:1636–1653. doi:https://doi.org/10.1002/anie.201205923
- Kubo AL, Capjak I, Vrček IV, Bondarenko OM, Kurvet I, Vija H, Ivask A, Kasemets K, Kahru A. Antimicrobial potency of differently coated 10 and 50 nm silver nanoparticles against clinically relevant bacteria Escherichia coli and Staphylococcus aureus. Colloids Surf B Biointerfaces Elsevier B V 2018;170:401–410. doi:https://doi.org/10.1016/j.colsurfb.2018.06.027
- Li Q, Wang M, Ge L, Li X, Ouyang J, Xing M. Nanosilver particles in medical applications: synthesis, performance, and toxicity. Int J Nanomedicine 2014;9:2399.
- Ahuja K, Deb S. Edible insects market size by product, by application, industry analysis report, regional outlook, application potential, price trends, competitive market share & forecast, 2018 – 2024. Global Information,Inc 2018.
- Statnano: nano science, technology and industry information. 2017. [cited 2020 Feb 02]Available from: https://product.statnano.com/industry/medicine
- Huang H, Lai W, Cui M, Liang L, Lin Y, Fang Q, Liu Y, Xie L. An evaluation of blood compatibility of silver nanoparticles. Sci Rep Nature Publishing Group 2016;6:25518.
- Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano 2009;3:1357–1364. doi:https://doi.org/10.1021/nn900277t
- Jun EA, Lim KM, Kim K, Bae ON, Noh JY, Chung KH, Chung JH. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology 2011;5:157–167. doi:https://doi.org/10.3109/17435390.2010.506250
- Laloy J, Minet V, Alpan L, Mullier F, Beken S, Toussaint O, Lucas S, Dogné J-M. Impact of silver nanoparticles on haemolysis, platelet function and coagulation. Nanobiomedicine 2014;1:4. doi:https://doi.org/10.5772/59346
- Lateef A, Ojo SA, Oladejo SM. Anti-candida, anti-coagulant and thrombolytic activities of biosynthesized silver nanoparticles using cell-free extract of Bacillus safensis LAU 13. Process Biochem Elsevier Ltd 2016;51:1406–1412. doi:https://doi.org/10.1016/j.procbio.2016.06.027
- Martínez-Gutierrez F, Thi EP, Silverman JM, de Oliveira CC, Svensson SL, Hoek AV, Sánchez EM, Reiner NE, Gaynor EC, Pryzdial ELG, et al. Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles. Nanomed Nanotechnol Biol Med. Elsevier Inc. 2012;8:328–336. doi:https://doi.org/10.1016/j.nano.2011.06.014.
- Stevens KNJ, Crespo-Biel O, EEM VDB, Dias AA, Knetsch MLW, Aldenhoff YBJ, van der Veen FH, Maessen JG, Stobberingh EE, Koole LH. The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood. Biomater Elsevier Ltd 2009;30:3682–3690. doi:https://doi.org/10.1016/j.biomaterials.2009.03.054
- Laloy J, Robert S, Marbehant C, Mullier F, Mejia J, Piret JP, Lucas S, Chatelain B, Dogné JM, Toussaint O, et al. Validation of the calibrated thrombin generation test (cTGT) as the reference assay to evaluate the procoagulant activity of nanomaterials. Nanotoxicology 2012;6:213–232. doi:https://doi.org/10.3109/17435390.2011.569096
- Zwart A, van Assendelft OW, Bull BS, England JM, Lewis SM, Zijlstra WG. Recommendations for reference method for haemoglobinometry in human blood (ICSH standard 1995) and specifications for international haemiglobinocyanide standard (4th edition). J Clin Pathol 1996;49:271–274. doi:https://doi.org/10.1136/jcp.49.4.271
- Vinković Vrček I, Pavičić I, Crnković T, Jurašin D, Babič M, Horák D, Lovrić M, Ferhatović L, Ćurlin M, Gajović S. Does surface coating of metallic nanoparticles modulate their interference with in vitro assays? RSC Adv 2015;5:70787–70807. doi:https://doi.org/10.1039/C5RA14100A
- Balasubramaniam P, Malathi A. Comparative study of hemoglobin estimated by Drabkin’s and Sahli’s methods. J Postgrad Med 1992;38:8–9.
- Oh SJ, Kim H, Liu Y, Han HK, Kwon K, Chang KH, Park K, Kim Y, Shim K, An SSA, et al. Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation. Toxicol Lett 2014;225:422–432. doi:https://doi.org/10.1016/j.toxlet.2014.01.015
- Fröhlich E. Action of nanoparticles on platelet activation and plasmatic coagulation. Curr Med Chem 2016;23:408–430. doi:https://doi.org/10.2174/0929867323666160106151428
- Tripodi A. Thrombin generation assay and its application in the clinical laboratory. Clin Chem 2016;62:699–707. doi:https://doi.org/10.1373/clinchem.2015.248625
- Lancé MD. A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J 2015;13:1. doi:https://doi.org/10.1186/1477-9560-13-1
- Domazet Jurašin D, Ćurlin M, Capjak I, Crnković T, Lovrić M, Babič M, Horák D, Vinković Vrček I, Gajović S. Surface coating affects behavior of metallic nanoparticles in a biological environment. Beilstein J Nanotechnol 2016;7:246–262. doi:https://doi.org/10.3762/bjnano.7.23
- Kwon T, Woo HJ, Kim YH, Lee HJ, Park KH, Park S, Youn B. Optimizing hemocompatibility of surfactant-coated silver nanoparticles in human erythrocytes. J Nanosci Nanotechnol 2012;12:6168–6175. doi:https://doi.org/10.1166/jnn.2012.6433
- Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 2010;40:328–346. doi:https://doi.org/10.3109/10408440903453074
- Wu Y. Contact pathway of coagulation and inflammation. Thromb J 2015;13:17. doi:https://doi.org/10.1186/s12959-015-0048-y
- de la Harpe K, Kondiah P, Choonara Y, Marimuthu T, du Toit L, Pillay V. The hemocompatibility of nanoparticles: a review of cell–nanoparticle interactions and hemostasis. Cells 2019;8:1209. doi:https://doi.org/10.3390/cells8101209
- Prietl B, Meindl C, Roblegg E, Pieber TR, Lanzer G, Fröhlich E. Nano-sized and micro-sized polystyrene particles affect phagocyte function. Cell Biol Toxicol 2014;30:1–16. doi:https://doi.org/10.1007/s10565-013-9265-y
- Sasidharan A, Riviere JE, Monteiro-Riviere NA. Gold and silver nanoparticle interactions with human proteins: impact and implications in biocorona formation. J Mater Chem B Royal Society of Chemistry 2015;3:2075–2082. doi:https://doi.org/10.1039/C4TB01926A
- Bandyopadhyay D, Baruah H, Gupta B, Sharma S. Silver nano particles prevent platelet adhesion on immobilized fibrinogen. Indian J Clin Biochem 2012;27:164–170. doi:https://doi.org/10.1007/s12291-011-0169-4
- Jaffer IH, Fredenburgh JC, Hirsh J, Weitz JI. Medical device-induced thrombosis: what causes it and how can we prevent it? J Thromb Haemost 2015;13:S72–81. doi:https://doi.org/10.1111/jth.12961
- Görlinger K, Dirkmann D, Hanke AA. Rotational thromboelastometry (ROTEM®). Trauma induced coagulopathy. Cham: Springer International Publishing; 2016. p. 267–298.
- Shankarraman V, Davis-Gorman G, Copeland JG, Caplan MR, McDonagh PF. Standardized methods to quantify thrombogenicity of blood-contacting materials via thromboelastography. J Biomed Mater Res - Part B Appl Biomater 2012;100:B: 230–8. doi:https://doi.org/10.1002/jbm.b.31942
- Ajdari N, Vyas C, Bogan SL, Lwaleed BA, Cousins BG. Gold nanoparticle interactions in human blood: a model evaluation. Nanomed Nanotechnol, Biol Med. Elsevier Inc. 2017;13:1531–1542. doi:https://doi.org/10.1016/j.nano.2017.01.019.